Surging Cases of Insomnia and Sleep Apnea to Accelerate Actigraphy Sensors Sales: Fact.MR

Poor and hectic lifestyle has increased the sleeping disorder cases exponentially in the working population across the globe, bolstering the demand for actigraphy sensors products

Fact.MR,: Award winning market research company Fact.MR is conducting an ongoing research study on the global actigraphy sensors market. As per its analysis, a positive growth outlook is expected for 2021, attributed to the rising prevalence of sleep disorders across the globe. Growth prospects for the upcoming decade are also optimistic, registering a noteworthy expansion rate until 2028.

According to the study, there has been a significant improvement in health awareness, assessment and expenditure with the rapid growth in economy. Following the outbreak of COVID-19, coupled with the rising diagnosis of sleep apnea, narcolepsy and insomnia, there has been a positive impact on actigraphy sensors growth. Expansion of healthcare structure and increase in number of patients with sleep disorder is aiding the sales.

For instance, according to the Centre for Disease Control and Prevention, in 2020, there has been an increase of 14% in the cases of sleep disorder with diseases such as sleep walking, night terrors in U.S., which prompted the manufacturers to invest heavily in research of advanced technology in the actigraphy sensors products. Hence, fostering the sales.

“New entrants are capitalizing on potential opportunities by incorporating the usage of artificial intelligence to create new growth opportunities in the upcoming years,” says the Fact.MR analyst.

Request a report sample to gain comprehensive insights at

Key Takeaways

  • Based on indication, insomnia is anticipated to gain popularity through 2021
  • Rising cases of insomnia and sleep apnea in U.S. to spearhead the North America growth
  • Europe expected to emerge as a lucrative market, followed by Asia Pacific
  • Rising cases of Narcolepsy in U.S. expected to accelerate actigraphy sensors sales
  • By product type, actigraphy watch is anticipated to prevail over other domains

Prominent Drivers

  • Rising prevalence of sleep disorders among corporate population to bolster the growth of actigraphy sensors
  • Adaption of new technology to penetrate the actigraphy market, to foster the sales
  • Innovations like actigraphy sensor watch and other advancement to create new growth opportunities for manufacturers
  • Ongoing development and research in the field of sleep disorder diseases to boost the demand  

Key Restraints

  • Less awareness about sleeping disorders and poor lifestyle restraining the growth of the market
  • High cost production to put a slight restrain on the manufacturers, hampering the sales

Discover more about the actigraphy sensors market with figures, data tables and the table of contents. You will also find detailed market segmentation on

Competitive Landscape

Philips Respironics, Aetna, and Activinsights are some of the key players profiled by Fact.MR. Key players are adopting numerous organic and inorganic strategies such as product innovation, collaborations, M&A’s, to strengthen their position in the market.

Recently, in March 2021, Philips Respironics reveals COVID-19’s a negative impact on sleep quality and CPAP use, which prompted them to increase the manufacturing of actigraphy watch devices to survey the sleep routine of their customers.

More Insights on the Actigraphy sensors Market

Fact.MR offers an unbiased analysis on the global actigraphy sensors market. The report divulges essential insights on actigraphy sensors market on the basis of product (watch and fitbit), indication (sleep apnea, insomnia, narcolepsy, restless leg syndrome, rapid eye movement behavior disorder, delayed sleep phase syndrome, and sleepwalking), application (sleep medicine, sleep disorder, circadian rhythm disorder, and daytime activity research), and regions (North America, Latin America, Europe, Japan, APEJ, and Middle East and Africa)

Request more information about Report Methodology

Explore Fact.MR’s Coverage on the Healthcare Domain

 Actigraphy Sensors & PSG Devices Market: A recent study by Fact.MR on the Actigraphy Sensors & PSG Devices market offers an unbiased analysis on the opportunities and challenges for the forecast period. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

 Medical devices technology Market: A detailed assessment of Medical devices technology value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the Medical devices technology market along with their product portfolios enhances the reliability of this comprehensive research study.  

 Genetic analyzer systems Market: The global peptide based genetic analyzer systems market report by Fact.MR delivers a detailed analysis on the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period. 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.    

Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR

Back to news